Clinical Data Disclosure and Transparency Resource Center
Brought to you by Applied Clinical Trials, The Clinical Data Disclosure and Transparency Resource Community is the go-to web destination for comprehensive data disclosure and transparency content.
Citeline Data Shows Higher Rate of Transparency Commitment
Sept. 10, 2014
TransCelerate Issues its CSR Redaction Approach for Data Sharing
Sept. 3, 2014
ECGCP Warns About Risks of Overprotecting Data
Aug. 1, 2014
ESMO's Concerns Over Data Protection and Research
July 25, 2014
Catching Up with Data Protection
July 21, 2014
EMA Delays Decision on Clinical Trial Data Until October
July 10, 2014
Pharma Improves Care by Sharing Clinical Trial Data
June 17, 2014
Privacy Analytics Launches Transparency Solution
June 18, 2014
Clinical Data Disclosure and Transparency
January 28-29, 2015 | Philadelphia, Pennsylvania
CBI’s successful inaugural event focusing on Clinical Data Disclosure and Transparency is back for its second year! This conference is the biggest of its kind and brings together high level executives to discuss and disseminate aspects of required data disclosure in a time of industry reform. Facing heightened pressure from the EMA, NIH, EFPIA, PhRMA and ICMJE to disclose clinical trial results and be transparent about all clinical trial data, this program focuses on the implications of and approaches being taken for data sharing, ensuring compliance with regulations, navigating disclosure requirements and releasing patient-level data.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
